This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!
 
Berkshire Hathaway Beats Q2 Earnings Amid Strengthening Economy

Berkshire Hathaway reported better than forecast second quarter earnings as sales growth at the Warren Buffett-run conglomerate returned.

Week Ahead: Econ Data and Michael Kors, Coach & CVS Report Earnings

Some big names on the earnings front include a couple of aspirational retailers, Michael Kors (KORS) and Coach (COH)

Unilever vs. Ben & Jerry's in Battle Over GMO Labeling

An internal battle between Unilever and subsidiary Ben & Jerry's may be forming, sparked by the debate about labeling food made with ingredients from genetically modified organisms.

July Auto Sales in Line as General Motors Outsells the Competition

General Motors was the top seller out of the U.S. automakers last month, reporting its best July sales since 2007 -- selling more than 256,000 vehicles, a 9.4% year-over-year increase.

Clorox Issues in Venezuela Kill Quarterly Sales Growth

Shares of Clorox are in focus on Friday after the household cleaning products company posted earnings below expectations due to sluggish demand and currency issues.

Real Money Previews

Cramer: When All Is Lost -- It's Not

We just have to wait for the complacent buyers to be blown away.

Kass: Avoid Most Social Media Stocks

A lot of things need to go well for the power of free to pay out all that it is promising.

Cramer: Russia's Impact Finally Being Felt

We're close to cutting numbers on major U.S. industrials now.

Mad Money Recap

'Mad Money' Lightning Round: Be Patient With Zynga

Cramer like Energy Transfer Partner's yield, would buy Kinder Morgan Energy Partners but thinks Pfizer is problematic.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to find the stocks he and Stephanie Link think could be HUGE winners. Click here to see them for FREE.

Stock Ideas

5 Toxic Stocks You Should Sell Before the Next Drop

It's time to unload these toxic stocks from your portfolio.

5 M&A Deal Stocks to Watch for Premium Gains

Mergers and acquisitions can provide amazing value for purchasing firms' balance sheets -- and instant gratification for shareholders in the target firm.

4 Biotech Stocks Under $10 to Trade for Breakouts

These under-$10 biotech stocks are within range of triggering breakout trades.

5 Breakout Stocks Under $10 Set to Soar

These stocks under $10 look ready to break out and trade higher from current levels.

Must-See Charts: 5 Big Stocks to Buy for Tactical Gains

Here's a look at how some of the biggest names on Wall Street are trading technically right now.

MainStreet

Young Americans Prefer Bank Investments, Not Stock Market

That's a problem, because younger Americans aren't going to meet their giant retirement savings burden with low-yielding cash investments.

Here's How to Fill All Those Empty Jobs

All we hear are stories about all the people who can't find work. It might be a good idea to spend at least a little time talking about it.

Economy Is Up, But More Americans Have Big Debt

There are ominous signs that the economy, especially as it relates to consumer spending, may fall under the weight of too much household debt.

10 Most Affordable Cars Of 2014

A car that eats up more than half of a household's annual income isn't 'affordable.' One that gives you Bluetooth, USB ports and five years of fuel for $23,000 is.

What's Hot in Home Construction Now -- and Hopefully When You Sell

A survey shows not only what's important for builders to add, but also what homeowners who plan to renovate existing properties should include.

Biotech

Cel-Sci's Enrollment Math Doesn't Add up

In order to enroll the remaining 648 patients into the Multikine study by the end of 2015, Cel-Sci needs to average 40.5 patients per month, or 121.5 patients per quarter.

Biotech Stock Mailbag: Arrowhead, Catalyst Pharma

Biotech columnist Adam Feuerstein answers readers' questions about health care.

Amarin Shocker: There's a Reason to be Bullish Right Now

If an FDA appeal decision goes in Amarin's favor, the stock is moving much higher.

Beyond Wall St.

Deal News

Berkshire Hathaway Earnings Confirm Warren Buffett’s Bet on U.S. Recovery

Berkshire Hathaway reported better than forecast second quarter earnings.

3 Reasons 21st Century Fox's Play for Time Warner Is a Long Shot

As Time Warner and Fox gear up to report earnings, a second-round offer could come sooner than later. But at what terms would Time Warner be willing to accept?

GoPro Wipes Out, LinkedIn Is Lights Out: Tech Winners & Losers

GoPro shares fell despite earnings beating consensus estimates, while Tesla and LinkedIn shares both jumped on strong results.

TheStreetTV
Spin Space

Jim Cramer

Cramer: When All Is Lost -- It's Not

We just have to wait for the complacent buyers to be blown away.

Herb Greenberg

Greenberg: Best Part About the Twitter Quarter

Twitter showed its willing to talk about its non-active users, the lurkers rather than the tweeters, and how to get everyone involved.

Stephanie Link

Oil Prices are Ridiculously Low Opportunity Still Abounds in E+P

Dan Dicker, Senior Energy contributor at Real Money, talks with Stephanie Link, co-portfolio manager at Action Alerts Plus about the current state of the oil market.

Chris Ciaccia

Tesla Earnings: What Wall Street's Saying

Tesla Motors continues to surprise investors on its way to producing 500,000 cars annually by 2020.

Adam Feuerstein

Cel-Sci's Enrollment Math Doesn't Add up

In order to enroll the remaining 648 patients into the Multikine study by the end of 2015, Cel-Sci needs to average 40.5 patients per month, or 121.5 patients per quarter.

Laurie Kulikowski

Michael Kors vs. Coach: Battle For Handbags, Watches and Shoes

Michael Kors and Coach are revving up for the fall season and it looks like each are playing to their strengths in the battle over the handbag and accessories categories.

Dan Freed

$25 Billion Deal and JPMorgan Stumble to Aid of Bronx Homeowner

The mortgage settlement with JPMorgan and four other banks included very little cash and led one Bronx woman down a circuitous, two-year path before her loan could be modified.

Rocco Pendola

Further Proof Microsoft Is Doomed By Apple and Google's Dominance

Apple and Google have already crushed Microsoft with consumers. Expect a similar trend with business customers.

Ted Reed

Ford, GM Say Auto Sales Are Not Overheated -- So Don't Panic

Ford and GM say continuing rapid auto sales gains are being fueled by a growing economy, replacement needs and low interest rates -- not by frothiness and easy credit.

Leon Lazaroff

Scripps' Rich Boehne Wants Local TV Broadcasters to Wake Up to Digital

Scripps' merger with Journal Communications isn't only about carving out low-growth newspapers; it's about remaking local TV-broadcasters for the digital era.

Submit an article to us!
DOW 16,493.37 -69.93 -0.42%
S&P 500 1,925.15 -5.52 -0.29%
NASDAQ 4,352.6390 -17.1340 -0.39%

Brokerage Partners

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs